Application of Cas12j for Streptomyces Editing
Biomolecules · 2024
DOI: 10.3390/biom14040486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Lee Ling Tan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos #07-06, Singapore 13…. Hauptthemen laut MEDLINE: Streptomyces, Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Agency for Science, Technology and Research, Singapore National Research Foundation (NRF)’s 19th Competitive Research Program (CRP).
Abstract (Originalsprache)
In recent years, CRISPR-Cas toolboxes for Streptomyces editing have rapidly accelerated natural product discovery and engineering. However, Cas efficiencies are oftentimes strain-dependent, and the commonly used Streptococcus pyogenes Cas9 (SpCas9) is notorious for having high levels of off-target toxicity effects. Thus, a variety of Cas proteins is required for greater flexibility of genetic manipulation within a wider range of Streptomyces strains. This study explored the first use of Acidaminococcus sp. Cas12j, a hypercompact Cas12 subfamily, for genome editing in Streptomyces and its potential in activating silent biosynthetic gene clusters (BGCs) to enhance natural product synthesis. While the editing efficiencies of Cas12j were not as high as previously reported efficiencies of Cas12a and Cas9, Cas12j exhibited higher transformation efficiencies compared to SpCas9. Furthermore, Cas12j demonstrated significantly improved editing efficiencies compared to Cas12a in activating BGCs in Streptomyces sp. A34053, a strain wherein both SpCas9 and Cas12a faced limitations in accessing the genome. Overall, this study expanded the repertoire of Cas proteins for genome editing in actinomycetes and highlighted not only the potential of recently characterized Cas12j in Streptomyces but also the importance of having an extensive genetic toolbox for improving the editing success of these beneficial microbes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos #07-06, Singapore 138673, Singapore.
- Singapore Institute of Food and Biotechnology Innovation (SIFBI), Agency for Science, Technology and Research (A*STAR), 31 Biopolis Way, Nanos #02-01, Singapore 138669, Singapore.
- Institute of Sustainability for Chemicals, Energy and Environment (ISCE2), Agency for Science, Technology and Research (A*STAR), 8 Biomedical Grove, Neuros #07-01, Singapore 138665, Singapore.
ORCID-Profile: Lee Ling Tan, Chung Yan Leong, Lay Kien Yang, Yoganathan Kanagasundaram, Guangrong Peh, Yee Hwee Lim, Fong Tian Wong
Förderung
- National Research Foundation
- Agency for Science, Technology and Research
- Singapore National Research Foundation (NRF)’s 19th Competitive Research Program (CRP)
- Agency for Science, Technology and Research (A*STAR), Singapore
Zitieren
APA
Tan, L. L., Heng, E., Leong, C. Y., Ng, V., Yang, L. K., Seow, D. C. S., Koduru, L., Kanagasundaram, Y., Ng, S. B., Peh, G., Lim, Y. H., & Wong, F. T. (2024). Application of Cas12j for Streptomyces Editing. Biomolecules. https://doi.org/10.3390/biom14040486
Vancouver
Tan LL, Heng E, Leong CY, Ng V, Yang LK, Seow DCS, et al. Application of Cas12j for Streptomyces Editing. Biomolecules. 2024. doi:10.3390/biom14040486
BibTeX
@article{Tan2024,
author = {Tan, Lee Ling and Heng, Elena and Leong, Chung Yan and Ng, Veronica and Yang, Lay Kien and Seow, Deborah Chwee San and Koduru, Lokanand and Kanagasundaram, Yoganathan and Ng, Siew Bee and Peh, Guangrong and Lim, Yee Hwee and Wong, Fong Tian},
title = {Application of Cas12j for Streptomyces Editing},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14040486}
}
EUVIMED